Abstract
Objective To investigate the efficacy of drug-coated balloon in treatment of femoropopliteal artery occlusive disease. Methods The clinical data of 49 patients with femoropopliteal artery occlusive disease from Feb 2016 to Oct 2017 were retrospectively analyzed. 25 cases underwent drug -coated balloon treatment (DCB group), and 24 cases received plain balloon angioplasty (POBA group). Results The procedures were successful in all cases. There were no amputation or death occurred.In DCB group compared to POBA group, the patency rate at postoperative 3 months were not significantly different (96.0% vs. 87.5%, P>0.05), while it was significantly different at postoperative 6 and 12 months (88.0% vs. 66.7%; 80.0% vs. 50.0%, both P 0.05). At 6 months and 12 months after operation, MLD of DCB group was higher than POBA group (P<0.05). At 12 months after surgery, LLL in DCB group was significantly lower than the POBA group (P<0.05). Conclusion DCB is the effective method to treat femoropopliteal artery occlusive disease, which has better short and mid-term efficacy than POBA. Key words: Arterial occlusive diseases; Angioplasty, balloon; Femoropopliteal artery
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
